PharmaLinea clinical trial finds >Your< Iron Forte Capsules match ferrous sulfate efficacy with improved tolerability

Private label supplement developer PharmaLinea announced the completion of a new clinical study evaluating the efficacy and tolerability of its finished iron formulation, >Your< Iron Forte Capsules, in adults with dietary iron deficiency.¹

Study design

The randomized, double-blind, 12-week trial, which is currently in the process of being published, enrolled 101 adults with mild to moderate, non-anemic iron deficiency. Participants followed a once-daily supplementation regimen of either >Your< Iron Forte Capsules or a low-dose ferrous sulfate comparator, namely, ferrous sulfate capsules. The primary end point was change in hemoglobin from baseline, with secondary measures including iron-related biomarkers and reported adverse events.

Results: improved iron status and reduced side effects

According to the company, the study demonstrated that >Your< Iron Forte Capsules delivered improvements in hemoglobin and iron status comparable to ferrous sulfate. Additionally, the formulation showed a more favorable tolerability profile, with significantly fewer side effects.

Iron deficiency prevalence

Gastrointestinal side effects from conventional iron supplements are a significant contributor to a lack of adherence to supplementation, the company notes, adding that iron deficiency remains the most prevalent micronutrient deficiency around the world, particularly affecting women of reproductive age and children.

It cites data from the World Health Organization (WHO) estimating that anemia impacts 40% of children aged 6–59 months, 37% of pregnant women, and 30% of women aged 15–49 years worldwide. The WHO’s health guidance emphasizes dietary diversification, improving infant feeding practices, and targeted supplementation to address these gaps.

PharmaLinea’s >Your< Iron Line

To help improve the iron intake management by addressing side effects from conventional supplements, PharmaLinea created the supplement line >Your< Iron Line, the company explains. Products have been introduced in 30 markets worldwide.

The product line has multiple clinical evaluations. “This is already the third study confirming the efficacy of the finished products in >Your< Iron Line, which has also received several industry awards,” explains PharmaLinea’s marketing director, Matevž Ambrožič.

In addition to the adult capsule data, the company’s portfolio includes a gold-standard clinical trial in iron-deficient children evaluating >Your< Iron Syrup, as well as preclinical comparisons to ferrous sulfate.

Beyond clinical substantiation, the >Your< Iron Line has also received multiple industry recognitions across global trade events and regional award platforms, reflecting an emphasis on scientific validation and consumer experience. The recognitions also include NutraIngredients – Asia Award for >Your< Iron Syrup, Best-Tasting Functional Beverage Award for >Your< Iron Syrup at Vitafoods Europe, and Best-Tasting Functional Beverage Award for >Your< Iron Forte Liquid Sticks at Vitafoods Europe.

Research on >Your< Back Pain Capsules

Other PharmaLinea supplements have also been evaluated in clinical studies. For example, a prospective, double-blind, randomized study, “Quality of Life in Patients with Lumbosacral Radicular Syndrome and Complete Rehabilitation Program (PRISUM PHSD/1/2022),” was published in April 2024 in Family Medicine and Primary Care: Open Access. This study examined the effect of >Your< Back Pain Capsules on back pain in adults.² The supplement contains the company’s proprietary Qspine, a nucleotide complex and vitamins B1, B6, B12, and D3, which aims to affect neuronal damage.

In this three-month study, 247 participants were treated with physical rehabilitation with the addition of >Your< Back Capsules daily, or with physical rehabilitation and a placebo. The participants in the supplement group experienced improvements in pain severity as well as improved pain-relieving and mobility effects from the physical therapy.

This article was created with assistance from AI. The content has been reviewed and edited by Erin McEvoy, Associate Editor. For more information on the extent and nature of AI usage, please contact us.

References

1. PharmaLinea. PharmaLinea’s iron supplement delivers improvements in hemoglobin comparable to ferrous sulfate with fewer side effects. (Accessed 2026-02-19).
2. McEvoy, E. New PharmaLinea lower back pain supplement tested in clinical trial. September 27, 2024. https://www.nutritionaloutlook.com/view/new-pharmalinea-lower-back-pain-supplement-tested-in-clinical-trial (Accessed 2026-02-19).